Blood purification could tackle COVID-19?

Coronavirus disease 2019 (COVID-19) threatened human lives worldwide since first reported. The current challenge for global intensivists is to establish an effective treatment for severe COVID-19. Blood purification has been applied to the treatment of various critical illnesses. Theoretically, its...

Full description

Saved in:
Bibliographic Details
Published inJournal of intensive care Vol. 9; no. 1; pp. 74 - 4
Main Authors Yamada, Hiroyuki, Ohtsuru, Shigeru
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 11.12.2021
BioMed Central
BMC
Subjects
AN69ST
Apheresis
Coronaviruses
COVID-19
Cytokines
Cytosorb
Extracorporeal membrane oxygenation
Health aspects
Medical colleges
Medical research
Medicine, Experimental
Mortality
Oxiris
Plasma exchange
Plasma exchange (Therapeutics)
Plasmapheresis
Plasma exchange
Coronavirus
Apheresis
Cytokine
Oxiris
Cytosorb
Pandemic
AN69ST
PMX-DHP
Plasmapheresis
Online AccessGet full text

Cover

More Information
Summary:Coronavirus disease 2019 (COVID-19) threatened human lives worldwide since first reported. The current challenge for global intensivists is to establish an effective treatment for severe COVID-19. Blood purification has been applied to the treatment of various critical illnesses. Theoretically, its technique also has an enormous possibility of treating severe COVID-19 in managing inflammatory cytokines and coagulopathy. Recent clinical studies have revealed the positive clinical effect of therapeutic plasma exchange. Other studies have also indicated the considerable potential of other blood purification techniques, such as Cytosorb, AN69 surface-treated membrane, and polymyxin b hemoperfusion. Further research is needed to elucidate the actual effects of these applications.
Bibliography:content type line 23
SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
ISSN:2052-0492
2052-0492
DOI:10.1186/s40560-021-00586-0